Trametinib (DMSO solvate)
10mM in DMSO
- Product Code: 239294
CAS:
1187431-43-1
| Molecular Weight: | 693.53 g./mol | Molecular Formula: | C₂₈H₂₉FIN₅O₅S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in cancer treatment, particularly for melanoma with BRAF V600E or V600K mutations. Works as a MEK inhibitor, blocking the activity of the MEK enzyme in the RAS/RAF/MEK/ERK signaling pathway, which controls cell division and survival. By inhibiting this pathway, it helps slow or stop the growth of cancer cells. Often used in combination with BRAF inhibitors like dabrafenib for enhanced efficacy. The DMSO solvate form is typically used in research settings for in vitro studies to maintain stability and solubility.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | ฿6,560.00 |
+
-
|
Trametinib (DMSO solvate)
Used in cancer treatment, particularly for melanoma with BRAF V600E or V600K mutations. Works as a MEK inhibitor, blocking the activity of the MEK enzyme in the RAS/RAF/MEK/ERK signaling pathway, which controls cell division and survival. By inhibiting this pathway, it helps slow or stop the growth of cancer cells. Often used in combination with BRAF inhibitors like dabrafenib for enhanced efficacy. The DMSO solvate form is typically used in research settings for in vitro studies to maintain stability and solubility.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :